Oral Session 3-11B AML: FLT3 mutations

[OS3-11B-1] Prognostic impact of acute myeloid leukemia with low allelic ratio FLT3-ITD and NPM1 mutation

Nana Nakajima¹, Masahiro Sakaguchi¹, Yuho Najima², Kensuke Usuki³, Toshimitsu Ueki⁴, Iekuni Oh⁵, Sinichiro Mori⁶, Eri Kawata⁷, Nobuhiko Uoshima⁷, Yutaka Kobayashi⁷, Shinichi Kako⁸, Kenji Tajika⁹, Seiji Gomi⁹, Katsuhiro Shono¹⁰, Kensuke Kayamori¹¹, Masao Hagihara¹², Junya Kanda¹³, Hitoji Uchiyama¹⁴, Junya Kuroda¹⁵, Naoyuki Uchida¹⁶, Yasushi Kubota¹⁷, Shinya Kimura¹⁷, Saiko Kurosawa¹⁸, Kunihito Arai¹, Kazuhiko Kakihana², Yoshinobu Kanda^5,8, Kazuteru Ohashi², Takahiro Fukuda¹⁸, Hiroki Yamaguchi¹, Koiti Inokuchi¹ (1.Department of Hematology, Nippon Medical School, Tokyo, Japan, 2.Hematology Division, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan, 3.Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan, 4.Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan, 5.Division of Hematology, Jichi Medical University, Tochigi, Japan, 6.Hemato-Oncology Department, St Lukes International Hospital, Tokyo, Japan, 7.Hematology Division, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan, 8.Hematology Division, Saitama Medical Center, Jichi Medical University, Saitama, Japan, 9.Department of Hematology, Yokohama Minami Kyousai Hospital, Kanagawa, Japan, 10.Department of Hematology, Chiba Aoba Municipal Hospital, Chiba, Japan, 11.Department of Hematology, Chiba University Hospital, Chiba, Japan, 12.Department of Hematology, Eiju General Hopital, Tokyo, Japan, 13.Department of Hematology and Oncology, Kyoto University, Kyoto, Japan., 14.Hematology Division, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan, 15.Hematology-and-Oncology Division, Kyoto Prefectural University of Medicine, Kyoto, Japan, 16.Department of Hematology, Toranomon Hospital, Tokyo, Japan, 17.Division of Hematology, Respiratory Medicine and Oncology,Saga University, Saga, Japan, 18.Department of HSCT, National Cancer Center Hospital, Tokyo, Japan)